Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenzhen Zhou

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|February 28, 2024
Structure-Based Design of Novel G-Protein-Coupled Receptor TAAR1 Agonists as Potential Antipsychotic Drug CandidatesZhenzhen Zhou, Weifeng Zhang, Fabao Zhao, et al.
Acta Pharmaceutica Sinica. B|July 19, 2024
Design and optimization of piperidine-substituted thiophene[3,2-<i>d</i>]pyrimidine-based HIV-1 NNRTIs with improved drug resistance and pharmacokinetic profilesYanying Sun, Zhenzhen Zhou, Zhongling Shi, et al.
European Journal of Medicinal Chemistry|July 24, 2025
Further exploring the tolerant region II: Identification of 2,4,5-trisubstituted pyrimidines as HIV-1 reverse transcriptase allosteric inhibitors with desirable antiviral activities and reduced cytotoxicityZhenzhen Zhou, Lin Zheng, Wenbo Jiang, et al.
European Journal of Medicinal Chemistry|August 2, 2024
Discovery of 2,4,6-trisubstituted pyrimidine derivatives as novel potent HIV-1 NNRTIs by exploiting the tolerant region II of the NNIBPZhenzhen Zhou, Yanying Sun, Yanyang Qin, et al.
Materials (Basel, Switzerland)|January 21, 2023
Eu<sup>3+</sup>-Doped (Gd, La)AlO<sub>3</sub> Perovskite Single Crystals: Growth and Red-Emitting LuminescenceTong Wu, Qian Zhang, Yun Shi, et al.
Journal of Medicinal Chemistry|May 8, 2025
In Silico Discovery of Novel Potent Trace Amine-Associated Receptor TAAR1 Agonists as Promising Drug Candidates for the Treatment of SchizophreniaZhenzhen Zhou, Weifeng Zhang, Fabao Zhao, et al.
Nature Reviews. Immunology|July 4, 2023
Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapiesZhenzhen Zhou, Yuan Pang, Jingyuan Ji, et al.
Journal of the American Heart Association|July 26, 2024
Midterm Outcomes of Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy: A Single-Center, Observational StudyXudong Xie, Siyuan Chen, Yawei Cui, et al.
International Journal of Molecular Sciences|June 19, 2024
<i>Bacillus altitudinis</i> AD13-4 Enhances Saline-Alkali Stress Tolerance of Alfalfa and Affects Composition of Rhizosphere Soil Microbial CommunityMuneer Ahmed Khoso, Mingyu Wang, Zhenzhen Zhou, et al.
European Journal of Medicinal Chemistry|March 6, 2025
Structure-based design of novel 2,4,5-trisubstituted pyrimidine derivatives as potent HIV-1 NNRTIs by exploiting the tolerant regions in NNTRIs binding pocketZhenzhen Zhou, Minghui Xie, Zongji Zhuo, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|February 28, 2024
Structure-Based Design of Novel G-Protein-Coupled Receptor TAAR1 Agonists as Potential Antipsychotic Drug CandidatesZhenzhen Zhou, Weifeng Zhang, Fabao Zhao, et al.
Acta Pharmaceutica Sinica. B|July 19, 2024
Design and optimization of piperidine-substituted thiophene[3,2-<i>d</i>]pyrimidine-based HIV-1 NNRTIs with improved drug resistance and pharmacokinetic profilesYanying Sun, Zhenzhen Zhou, Zhongling Shi, et al.
European Journal of Medicinal Chemistry|July 24, 2025
Further exploring the tolerant region II: Identification of 2,4,5-trisubstituted pyrimidines as HIV-1 reverse transcriptase allosteric inhibitors with desirable antiviral activities and reduced cytotoxicityZhenzhen Zhou, Lin Zheng, Wenbo Jiang, et al.
European Journal of Medicinal Chemistry|August 2, 2024
Discovery of 2,4,6-trisubstituted pyrimidine derivatives as novel potent HIV-1 NNRTIs by exploiting the tolerant region II of the NNIBPZhenzhen Zhou, Yanying Sun, Yanyang Qin, et al.
Materials (Basel, Switzerland)|January 21, 2023
Eu<sup>3+</sup>-Doped (Gd, La)AlO<sub>3</sub> Perovskite Single Crystals: Growth and Red-Emitting LuminescenceTong Wu, Qian Zhang, Yun Shi, et al.
Journal of Medicinal Chemistry|May 8, 2025
In Silico Discovery of Novel Potent Trace Amine-Associated Receptor TAAR1 Agonists as Promising Drug Candidates for the Treatment of SchizophreniaZhenzhen Zhou, Weifeng Zhang, Fabao Zhao, et al.
Nature Reviews. Immunology|July 4, 2023
Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapiesZhenzhen Zhou, Yuan Pang, Jingyuan Ji, et al.
Journal of the American Heart Association|July 26, 2024
Midterm Outcomes of Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy: A Single-Center, Observational StudyXudong Xie, Siyuan Chen, Yawei Cui, et al.
International Journal of Molecular Sciences|June 19, 2024
<i>Bacillus altitudinis</i> AD13-4 Enhances Saline-Alkali Stress Tolerance of Alfalfa and Affects Composition of Rhizosphere Soil Microbial CommunityMuneer Ahmed Khoso, Mingyu Wang, Zhenzhen Zhou, et al.
European Journal of Medicinal Chemistry|March 6, 2025
Structure-based design of novel 2,4,5-trisubstituted pyrimidine derivatives as potent HIV-1 NNRTIs by exploiting the tolerant regions in NNTRIs binding pocketZhenzhen Zhou, Minghui Xie, Zongji Zhuo, et al.
Pageof 11